News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
731,481 Results
Type
Article (41621)
Company Profile (267)
Press Release (689576)
Multimedia
Podcasts (94)
Webinars (21)
Section
Business (204999)
Career Advice (2035)
Deals (35605)
Drug Delivery (128)
Drug Development (81652)
Employer Resources (173)
FDA (16521)
Job Trends (14990)
News (347142)
Policy (32796)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2600)
Accelerated approval (47)
Adcomms (27)
Allergies (171)
Alliances (49623)
ALS (210)
Alzheimer's disease (1794)
Antibody-drug conjugate (ADC) (442)
Approvals (16897)
Artificial intelligence (658)
Autoimmune disease (290)
Automation (56)
Bankruptcy (362)
Best Places to Work (11641)
BIOSECURE Act (20)
Biosimilars (220)
Biotechnology (177)
Bladder cancer (187)
Brain cancer (71)
Breast cancer (747)
Cancer (5787)
Cardiovascular disease (477)
Career advice (1726)
Career pathing (42)
CAR-T (334)
CDC (57)
Celiac Disease (3)
Cell therapy (902)
Cervical cancer (47)
Clinical research (70882)
Collaboration (2049)
Company closure (5)
Compensation (1388)
Complete response letters (79)
COVID-19 (2754)
CRISPR (110)
C-suite (1118)
Cystic fibrosis (153)
Data (7849)
Decentralized trials (3)
Denatured (27)
Depression (160)
Dermatology (86)
Diabetes (587)
Diagnostics (6930)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (318)
Drug pricing (202)
Drug shortages (31)
Duchenne muscular dystrophy (283)
Earnings (92103)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (119604)
Executive appointments (1078)
FDA (20231)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (34)
Funding (1726)
Gene editing (239)
Generative AI (56)
Gene therapy (721)
GLP-1 (1057)
Government (4735)
Grass and pollen (6)
Guidances (408)
Healthcare (19009)
HIV (79)
Huntington's disease (56)
IgA nephropathy (98)
Immunology and inflammation (287)
Immuno-oncology (92)
Indications (191)
Infectious disease (3092)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (137)
Intellectual property (288)
Interviews (320)
IPO (16681)
IRA (50)
Job creations (3651)
Job search strategy (1432)
JPM (58)
Kidney cancer (19)
Labor market (99)
Layoffs (564)
Leadership (39)
Legal (7965)
Liver cancer (99)
Longevity (32)
Lung cancer (760)
Lymphoma (430)
Machine learning (60)
Management (59)
Manufacturing (1044)
MASH (188)
Medical device (13946)
Medtech (14067)
Mergers & acquisitions (20167)
Metabolic disorders (1502)
mRNA (210)
Multiple sclerosis (187)
NASH (18)
Neurodegenerative disease (412)
Neuropsychiatric disorders (105)
Neuroscience (3294)
Neurotech (1)
NextGen: Class of 2026 (6533)
Non-profit (4532)
Now hiring (78)
Obesity (702)
Opinion (287)
Ovarian cancer (218)
Pain (253)
Pancreatic cancer (299)
Parkinson's disease (358)
Partnered (33)
Patents (594)
Patient recruitment (668)
Peanut (62)
People (59605)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (22105)
Phase 2 (31227)
Phase 3 (23231)
Pipeline (8669)
Policy (315)
Postmarket research (2573)
Preclinical (9427)
Press Release (64)
Prostate cancer (298)
Psychedelics (54)
Radiopharmaceuticals (320)
Rare diseases (1080)
Real estate (5977)
Recruiting (70)
Regulatory (25412)
Reports (56)
Research institute (2415)
Resumes & cover letters (353)
Rett syndrome (39)
RNA editing (21)
RSV (88)
Schizophrenia (176)
Series A (289)
Series B (216)
Service/supplier (11)
Sickle cell disease (117)
Special edition (23)
Spinal muscular atrophy (166)
Sponsored (48)
Startups (3654)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (89)
The Weekly (63)
Vaccines (1100)
Venture capital (109)
Weight loss (455)
Women's health (125)
Worklife (20)
Date
Today (183)
Last 7 days (849)
Last 30 days (3571)
Last 365 days (30213)
2026 (12366)
2025 (30228)
2024 (35249)
2023 (40112)
2022 (51217)
2021 (55741)
2020 (54117)
2019 (46598)
2018 (35048)
2017 (32133)
2016 (31509)
2015 (37607)
2014 (31381)
2013 (26402)
2012 (28610)
2011 (29310)
2010 (27387)
Location
Africa (742)
Alabama (93)
Alaska (7)
Arizona (348)
Arkansas (14)
Asia (39785)
Australia (6510)
California (13242)
Canada (3760)
China (1338)
Colorado (566)
Connecticut (574)
Delaware (403)
Europe (86022)
Florida (1983)
Georgia (424)
Hawaii (3)
Idaho (62)
Illinois (1051)
India (90)
Indiana (598)
Iowa (24)
Japan (534)
Kansas (131)
Kentucky (50)
Louisiana (41)
Maine (76)
Maryland (1586)
Massachusetts (9459)
Michigan (362)
Minnesota (715)
Mississippi (6)
Missouri (144)
Montana (33)
Nebraska (29)
Nevada (142)
New Hampshire (84)
New Jersey (3478)
New Mexico (29)
New York (3462)
North Carolina (1678)
North Dakota (10)
Northern California (6641)
Ohio (396)
Oklahoma (23)
Oregon (41)
Pennsylvania (2661)
Puerto Rico (29)
Rhode Island (50)
South America (1113)
South Carolina (85)
South Dakota (2)
Southern California (5219)
Tennessee (210)
Texas (2098)
United States (46702)
Utah (397)
Vermont (1)
Virginia (321)
Washington D.C. (80)
Washington State (1056)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
731,481 Results for "avanti polar lipids inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Peli BioThermal Announces Strategic Partnership with Polar Group in Brazil
March 3, 2026
·
3 min read
Press Releases
Glycomine Completes Enrollment in Global Phase 2b POLAR Study of GLM101 for the Treatment of PMM2-CDG
April 2, 2026
·
3 min read
Press Releases
Polares Medical Raises $50 Million Series C to Advance U.S. Expansion of MRace Following Strong Clinical Results
March 4, 2026
·
2 min read
Press Releases
ACC/AHA Issue Updated Guideline for Managing Lipids, Cholesterol
March 15, 2026
·
11 min read
Press Releases
Hopewell Therapeutics Announces Sublicense of Proprietary Lipid Nanoparticles for Novel Cancer Vaccine to Foxcroft Therapeutics
March 5, 2026
·
3 min read
Press Releases
Bruker Announces Introduction of Revolutionary d-DNP Polarizer for MRI Research and for Dynamic Nuclear Polarization Liquids NMR
April 2, 2025
·
4 min read
Deals
Avanti Polar Lipids Agrees to be Acquired by Croda
Avanti combining with Croda to expand life sciences products, pharmaceutical services and cGMP production capabilities for biotechnology, pharmaceutical and life science research customers globally Avanti will continue to operate under the Avanti brand and be led by the current management team [06-July-2020] ALABASTER, Alabama , July 6, 2020 /PRNewswire/ --
July 6, 2020
·
4 min read
Press Releases
Hoth Therapeutics Reports Positive Female Preclinical Data Showing HT-VA Restores Cholesterol Levels and Improves Lipid Metabolism in MASLD Model
March 10, 2026
·
6 min read
Editorial
RFK Jr. Is Driving a Wedge Into Already Polarized Vaccine Conversations
When it comes to vaccination, the COVID-19 pandemic divided American society. President Donald Trump and his new Health and Human Services secretary are bringing down the hammer. What happens when there is no middle ground?
May 1, 2025
·
7 min read
·
Jef Akst
Press Releases
Cayman Chemical and Curapath Partner to Provide Wider Access to PEG-Free Shielding Lipids for Lipid Nanoparticles
September 3, 2025
·
1 min read
1 of 73,149
Next
